| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 5 | 2023 | 106 | 3.940 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2023 | 32 | 3.490 |
Why?
|
| Mouth Neoplasms | 8 | 2022 | 70 | 3.110 |
Why?
|
| Blood Proteins | 6 | 2024 | 65 | 2.820 |
Why?
|
| Myocardial Reperfusion Injury | 5 | 2023 | 54 | 2.240 |
Why?
|
| Bacteria | 4 | 2024 | 245 | 1.830 |
Why?
|
| Photochemotherapy | 3 | 2022 | 37 | 1.720 |
Why?
|
| Alzheimer Disease | 4 | 2024 | 881 | 1.630 |
Why?
|
| Tobacco Mosaic Virus | 2 | 2021 | 5 | 1.580 |
Why?
|
| Leukoplakia, Oral | 6 | 2022 | 11 | 1.580 |
Why?
|
| Laser Therapy | 2 | 2021 | 30 | 1.540 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2024 | 528 | 1.520 |
Why?
|
| Reactive Oxygen Species | 5 | 2023 | 416 | 1.430 |
Why?
|
| Plant Growth Regulators | 2 | 2019 | 16 | 1.410 |
Why?
|
| Metals, Heavy | 2 | 2019 | 56 | 1.350 |
Why?
|
| Prostatic Neoplasms | 3 | 2023 | 794 | 1.330 |
Why?
|
| Soil Pollutants | 2 | 2019 | 86 | 1.310 |
Why?
|
| DNA Methylation | 2 | 2021 | 301 | 1.270 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2022 | 176 | 1.250 |
Why?
|
| Myocardial Ischemia | 4 | 2023 | 72 | 1.240 |
Why?
|
| Ischemic Preconditioning, Myocardial | 3 | 2023 | 13 | 1.240 |
Why?
|
| China | 15 | 2022 | 178 | 1.240 |
Why?
|
| STAT3 Transcription Factor | 2 | 2019 | 80 | 1.170 |
Why?
|
| Genetic Association Studies | 4 | 2021 | 102 | 1.130 |
Why?
|
| Humans | 51 | 2024 | 34853 | 1.120 |
Why?
|
| Phytoplankton | 3 | 2023 | 5 | 1.040 |
Why?
|
| Lasers, Solid-State | 2 | 2022 | 13 | 1.040 |
Why?
|
| Seasons | 3 | 2022 | 112 | 1.040 |
Why?
|
| Genome-Wide Association Study | 6 | 2024 | 271 | 1.040 |
Why?
|
| Soil Microbiology | 4 | 2024 | 48 | 1.030 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2023 | 8 | 1.020 |
Why?
|
| Gene Expression Profiling | 4 | 2023 | 600 | 0.990 |
Why?
|
| Isodon | 1 | 2023 | 1 | 0.980 |
Why?
|
| Diterpenes, Kaurane | 1 | 2023 | 1 | 0.980 |
Why?
|
| Brucella abortus | 1 | 2023 | 5 | 0.970 |
Why?
|
| Brucellosis | 1 | 2023 | 8 | 0.970 |
Why?
|
| Case-Control Studies | 8 | 2021 | 1056 | 0.940 |
Why?
|
| Thyroid Neoplasms | 1 | 2023 | 35 | 0.930 |
Why?
|
| Proteomics | 3 | 2024 | 302 | 0.920 |
Why?
|
| Prostatic Hyperplasia | 2 | 2021 | 33 | 0.920 |
Why?
|
| Precancerous Conditions | 2 | 2021 | 81 | 0.910 |
Why?
|
| Fresh Water | 3 | 2018 | 47 | 0.870 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2023 | 107 | 0.870 |
Why?
|
| Prostate | 2 | 2021 | 136 | 0.850 |
Why?
|
| Carcinoma, Verrucous | 1 | 2021 | 1 | 0.840 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 119 | 0.840 |
Why?
|
| Wetlands | 2 | 2020 | 15 | 0.830 |
Why?
|
| Carcinoma in Situ | 1 | 2021 | 13 | 0.830 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 147 | 0.820 |
Why?
|
| Heart Ventricles | 2 | 2021 | 121 | 0.800 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2020 | 11 | 0.780 |
Why?
|
| Coprinus | 1 | 2019 | 1 | 0.740 |
Why?
|
| Ecosystem | 4 | 2024 | 119 | 0.730 |
Why?
|
| Biodiversity | 2 | 2018 | 81 | 0.720 |
Why?
|
| Sorghum | 1 | 2019 | 4 | 0.720 |
Why?
|
| Microbial Interactions | 1 | 2019 | 10 | 0.710 |
Why?
|
| Mining | 1 | 2019 | 16 | 0.710 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 245 | 0.700 |
Why?
|
| Periodontal Diseases | 1 | 2019 | 49 | 0.700 |
Why?
|
| Calcium Channels | 1 | 2019 | 72 | 0.690 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2024 | 638 | 0.690 |
Why?
|
| Myocytes, Cardiac | 5 | 2023 | 165 | 0.660 |
Why?
|
| Actinomycetales | 1 | 2018 | 5 | 0.660 |
Why?
|
| Burkholderia | 1 | 2018 | 17 | 0.650 |
Why?
|
| Water Microbiology | 1 | 2018 | 72 | 0.630 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2017 | 2 | 0.620 |
Why?
|
| Risk Factors | 8 | 2024 | 3414 | 0.620 |
Why?
|
| Lagomorpha | 1 | 2017 | 1 | 0.610 |
Why?
|
| Pest Control | 1 | 2017 | 3 | 0.610 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2017 | 26 | 0.600 |
Why?
|
| Poaceae | 1 | 2017 | 11 | 0.600 |
Why?
|
| Fungi | 1 | 2018 | 86 | 0.590 |
Why?
|
| HIV-1 | 8 | 2015 | 678 | 0.590 |
Why?
|
| Proteome | 2 | 2017 | 132 | 0.580 |
Why?
|
| Chlorophyll | 2 | 2023 | 22 | 0.560 |
Why?
|
| Animals | 23 | 2023 | 14307 | 0.540 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 6 | 0.530 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 31 | 0.520 |
Why?
|
| Male | 21 | 2023 | 18870 | 0.520 |
Why?
|
| Soil | 4 | 2024 | 129 | 0.520 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2023 | 1534 | 0.510 |
Why?
|
| Pancreas | 2 | 2023 | 32 | 0.470 |
Why?
|
| Sewage | 2 | 2022 | 16 | 0.430 |
Why?
|
| Photosensitizing Agents | 3 | 2022 | 47 | 0.430 |
Why?
|
| Rats | 9 | 2023 | 3261 | 0.430 |
Why?
|
| Calcium | 1 | 2015 | 445 | 0.420 |
Why?
|
| RNA, Ribosomal, 16S | 4 | 2024 | 165 | 0.420 |
Why?
|
| Plant Proteins | 3 | 2021 | 93 | 0.410 |
Why?
|
| Signal Transduction | 7 | 2021 | 1802 | 0.400 |
Why?
|
| Periodontitis | 2 | 2021 | 52 | 0.400 |
Why?
|
| Aminolevulinic Acid | 2 | 2021 | 8 | 0.390 |
Why?
|
| CpG Islands | 2 | 2021 | 91 | 0.390 |
Why?
|
| AIDS Vaccines | 5 | 2010 | 30 | 0.390 |
Why?
|
| Prognosis | 4 | 2024 | 707 | 0.390 |
Why?
|
| Plant Diseases | 2 | 2021 | 52 | 0.380 |
Why?
|
| Biodegradation, Environmental | 2 | 2019 | 76 | 0.350 |
Why?
|
| Petunia | 2 | 2019 | 4 | 0.350 |
Why?
|
| Genotype | 4 | 2019 | 641 | 0.350 |
Why?
|
| Lymphocyte Activation | 2 | 2022 | 222 | 0.330 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 150 | 0.330 |
Why?
|
| Mice | 9 | 2023 | 5668 | 0.320 |
Why?
|
| Water Pollution | 1 | 2007 | 10 | 0.320 |
Why?
|
| Photosynthesis | 1 | 2007 | 28 | 0.320 |
Why?
|
| Aged | 8 | 2020 | 6448 | 0.310 |
Why?
|
| Flavones | 2 | 2022 | 8 | 0.300 |
Why?
|
| Phylogeny | 5 | 2023 | 612 | 0.300 |
Why?
|
| Risk | 3 | 2023 | 256 | 0.300 |
Why?
|
| Mitochondria, Heart | 3 | 2019 | 66 | 0.300 |
Why?
|
| Middle Aged | 10 | 2020 | 9642 | 0.300 |
Why?
|
| Antibodies, Viral | 3 | 2014 | 252 | 0.290 |
Why?
|
| Transcription Factors | 2 | 2024 | 653 | 0.280 |
Why?
|
| Antibody Specificity | 1 | 2006 | 75 | 0.280 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2006 | 54 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 592 | 0.280 |
Why?
|
| Chromatin | 2 | 2024 | 164 | 0.270 |
Why?
|
| Conservation of Natural Resources | 2 | 2017 | 32 | 0.260 |
Why?
|
| Retrospective Studies | 5 | 2023 | 1961 | 0.260 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2023 | 107 | 0.260 |
Why?
|
| Hyperplasia | 2 | 2021 | 38 | 0.260 |
Why?
|
| Molecular Structure | 2 | 2023 | 467 | 0.250 |
Why?
|
| Antibodies, Neutralizing | 3 | 2015 | 102 | 0.250 |
Why?
|
| Repressor Proteins | 2 | 2024 | 226 | 0.250 |
Why?
|
| Plant Components, Aerial | 1 | 2023 | 2 | 0.250 |
Why?
|
| Female | 16 | 2023 | 19873 | 0.250 |
Why?
|
| Esters | 1 | 2023 | 28 | 0.240 |
Why?
|
| Peptide Fragments | 1 | 2006 | 298 | 0.240 |
Why?
|
| Artemisia | 1 | 2023 | 4 | 0.240 |
Why?
|
| Nucleotides | 1 | 2023 | 33 | 0.240 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 608 | 0.240 |
Why?
|
| Organic Chemicals | 1 | 2024 | 35 | 0.240 |
Why?
|
| Myocardium | 3 | 2015 | 224 | 0.240 |
Why?
|
| Artemisia annua | 1 | 2023 | 1 | 0.240 |
Why?
|
| Water | 2 | 2023 | 283 | 0.240 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 104 | 0.240 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 4 | 2015 | 18 | 0.240 |
Why?
|
| Gene Frequency | 3 | 2018 | 155 | 0.240 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2023 | 20 | 0.240 |
Why?
|
| Apoptosis | 3 | 2021 | 1317 | 0.240 |
Why?
|
| RNA Splicing | 1 | 2023 | 36 | 0.230 |
Why?
|
| Canada | 1 | 2023 | 121 | 0.230 |
Why?
|
| Artemisinins | 1 | 2023 | 17 | 0.230 |
Why?
|
| Reperfusion | 1 | 2023 | 15 | 0.230 |
Why?
|
| Myocardial Contraction | 2 | 2015 | 47 | 0.230 |
Why?
|
| Volatile Organic Compounds | 1 | 2023 | 15 | 0.230 |
Why?
|
| Cell Proliferation | 5 | 2021 | 1149 | 0.230 |
Why?
|
| Cell Adhesion Molecules | 1 | 2023 | 70 | 0.230 |
Why?
|
| Bacteroidetes | 1 | 2022 | 9 | 0.230 |
Why?
|
| Adult | 10 | 2023 | 11034 | 0.230 |
Why?
|
| Metabolome | 1 | 2023 | 47 | 0.220 |
Why?
|
| Ischemia | 1 | 2023 | 45 | 0.220 |
Why?
|
| Genome, Plant | 2 | 2019 | 26 | 0.220 |
Why?
|
| Sequence Analysis, DNA | 3 | 2019 | 455 | 0.220 |
Why?
|
| Apigenin | 1 | 2022 | 12 | 0.220 |
Why?
|
| Treatment Outcome | 3 | 2022 | 1349 | 0.220 |
Why?
|
| Retinal Dehydrogenase | 2 | 2012 | 11 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 480 | 0.220 |
Why?
|
| Multigene Family | 2 | 2019 | 105 | 0.220 |
Why?
|
| Hydrogen Peroxide | 1 | 2023 | 181 | 0.210 |
Why?
|
| Aquaporin 2 | 1 | 2021 | 1 | 0.210 |
Why?
|
| Salicylic Acid | 1 | 2021 | 6 | 0.210 |
Why?
|
| Cell Cycle | 2 | 2021 | 309 | 0.210 |
Why?
|
| Nitrogen | 2 | 2024 | 63 | 0.210 |
Why?
|
| Recombinant Proteins | 2 | 2022 | 485 | 0.210 |
Why?
|
| Urogenital Neoplasms | 1 | 2021 | 2 | 0.210 |
Why?
|
| Isoenzymes | 2 | 2012 | 149 | 0.210 |
Why?
|
| Heart Diseases | 1 | 2023 | 99 | 0.210 |
Why?
|
| Muscle Proteins | 1 | 2021 | 48 | 0.210 |
Why?
|
| Neoplastic Stem Cells | 2 | 2012 | 74 | 0.210 |
Why?
|
| Terminology as Topic | 1 | 2021 | 32 | 0.210 |
Why?
|
| Carbon | 2 | 2024 | 95 | 0.210 |
Why?
|
| Chemical Phenomena | 2 | 2019 | 53 | 0.210 |
Why?
|
| Waste Disposal, Fluid | 1 | 2021 | 14 | 0.210 |
Why?
|
| Mouth Mucosa | 1 | 2021 | 33 | 0.200 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 570 | 0.200 |
Why?
|
| Gene Expression | 3 | 2021 | 639 | 0.200 |
Why?
|
| Hydrogen Sulfide | 1 | 2021 | 38 | 0.200 |
Why?
|
| ROC Curve | 2 | 2020 | 138 | 0.200 |
Why?
|
| Insulin Resistance | 1 | 2022 | 177 | 0.190 |
Why?
|
| Incidence | 1 | 2023 | 882 | 0.190 |
Why?
|
| Image Cytometry | 1 | 2020 | 6 | 0.190 |
Why?
|
| Chromatography, Liquid | 2 | 2022 | 140 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 184 | 0.190 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 112 | 0.190 |
Why?
|
| Aneuploidy | 1 | 2020 | 20 | 0.190 |
Why?
|
| Fluorescent Dyes | 1 | 2021 | 173 | 0.190 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 841 | 0.190 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 120 | 0.190 |
Why?
|
| Survival Rate | 1 | 2021 | 310 | 0.190 |
Why?
|
| Antiviral Agents | 1 | 2021 | 148 | 0.190 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2022 | 173 | 0.190 |
Why?
|
| Cytokines | 2 | 2021 | 569 | 0.190 |
Why?
|
| Models, Genetic | 1 | 2020 | 149 | 0.190 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 2333 | 0.180 |
Why?
|
| Carcinoma | 1 | 2020 | 94 | 0.180 |
Why?
|
| Ionic Liquids | 1 | 2019 | 16 | 0.180 |
Why?
|
| Carbon Dioxide | 1 | 2019 | 78 | 0.180 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 336 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 206 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2018 | 224 | 0.170 |
Why?
|
| Pilot Projects | 1 | 2021 | 628 | 0.170 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 63 | 0.170 |
Why?
|
| Imidazoles | 1 | 2019 | 124 | 0.170 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 70 | 0.170 |
Why?
|
| Genes, erbB-1 | 1 | 2018 | 3 | 0.170 |
Why?
|
| Proteins | 2 | 2013 | 352 | 0.170 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 133 | 0.170 |
Why?
|
| Phenotype | 1 | 2021 | 650 | 0.170 |
Why?
|
| Inferior Wall Myocardial Infarction | 1 | 2018 | 2 | 0.170 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 413 | 0.170 |
Why?
|
| Plants | 1 | 2019 | 94 | 0.170 |
Why?
|
| Endothelial Cells | 1 | 2021 | 296 | 0.170 |
Why?
|
| Linkage Disequilibrium | 1 | 2018 | 58 | 0.170 |
Why?
|
| Plants, Medicinal | 1 | 2019 | 54 | 0.170 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 184 | 0.170 |
Why?
|
| Drug Carriers | 2 | 2009 | 121 | 0.170 |
Why?
|
| RNA, Bacterial | 1 | 2018 | 29 | 0.160 |
Why?
|
| DNA Fingerprinting | 1 | 2018 | 18 | 0.160 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2018 | 29 | 0.160 |
Why?
|
| Haplotypes | 1 | 2018 | 152 | 0.160 |
Why?
|
| Erythroplasia | 2 | 2020 | 2 | 0.160 |
Why?
|
| Aminacrine | 1 | 2017 | 1 | 0.160 |
Why?
|
| Antioxidants | 2 | 2019 | 386 | 0.160 |
Why?
|
| Coronary Vessels | 1 | 2018 | 93 | 0.160 |
Why?
|
| Phosphorus | 1 | 2018 | 64 | 0.160 |
Why?
|
| Ovulation Induction | 1 | 2017 | 6 | 0.160 |
Why?
|
| Electrocardiography | 1 | 2018 | 154 | 0.150 |
Why?
|
| Lung | 1 | 2020 | 413 | 0.150 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2017 | 41 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 445 | 0.150 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2018 | 151 | 0.150 |
Why?
|
| Tibet | 1 | 2017 | 2 | 0.150 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2014 | 166 | 0.150 |
Why?
|
| Fertilization in Vitro | 1 | 2017 | 56 | 0.150 |
Why?
|
| Population Density | 1 | 2017 | 19 | 0.150 |
Why?
|
| Plant Roots | 1 | 2019 | 153 | 0.150 |
Why?
|
| Archaea | 1 | 2016 | 14 | 0.150 |
Why?
|
| Geologic Sediments | 1 | 2016 | 41 | 0.150 |
Why?
|
| Logistic Models | 1 | 2019 | 894 | 0.150 |
Why?
|
| Benzofurans | 1 | 2016 | 19 | 0.140 |
Why?
|
| Cross Reactions | 2 | 2014 | 83 | 0.140 |
Why?
|
| Cell Line | 4 | 2021 | 1289 | 0.140 |
Why?
|
| Aggressive Periodontitis | 1 | 2016 | 2 | 0.140 |
Why?
|
| Gene Expression Regulation, Plant | 3 | 2023 | 58 | 0.140 |
Why?
|
| Tuberculosis | 1 | 2016 | 56 | 0.140 |
Why?
|
| Oxidative Stress | 1 | 2021 | 874 | 0.140 |
Why?
|
| Head and Neck Neoplasms | 1 | 2016 | 73 | 0.140 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2016 | 84 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 781 | 0.140 |
Why?
|
| Immunologic Factors | 1 | 2015 | 44 | 0.130 |
Why?
|
| Young Adult | 4 | 2020 | 4012 | 0.130 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 756 | 0.130 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 108 | 0.130 |
Why?
|
| Free Radical Scavengers | 1 | 2015 | 65 | 0.130 |
Why?
|
| Vaccines, DNA | 4 | 2010 | 23 | 0.130 |
Why?
|
| Antigens, CD | 2 | 2012 | 116 | 0.130 |
Why?
|
| Nanoparticles | 2 | 2016 | 294 | 0.130 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2014 | 1 | 0.120 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2014 | 13 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 139 | 0.120 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2014 | 7 | 0.120 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2014 | 47 | 0.120 |
Why?
|
| Receptors, Calcitriol | 1 | 2014 | 59 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 40 | 0.120 |
Why?
|
| Neoplasms | 1 | 2024 | 1033 | 0.120 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 901 | 0.120 |
Why?
|
| Panthera | 1 | 2013 | 1 | 0.120 |
Why?
|
| Buddhism | 1 | 2013 | 2 | 0.120 |
Why?
|
| Reperfusion Injury | 1 | 2014 | 53 | 0.120 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2014 | 62 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 325 | 0.120 |
Why?
|
| HIV Antibodies | 2 | 2010 | 29 | 0.120 |
Why?
|
| Molecular Chaperones | 1 | 2014 | 61 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 39 | 0.120 |
Why?
|
| Protein Interaction Mapping | 2 | 2014 | 57 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 251 | 0.120 |
Why?
|
| Zinc Compounds | 1 | 2013 | 12 | 0.120 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 2561 | 0.120 |
Why?
|
| Influenza Vaccines | 1 | 2014 | 50 | 0.120 |
Why?
|
| Lidocaine | 2 | 2009 | 15 | 0.110 |
Why?
|
| Serum Albumin, Bovine | 1 | 2013 | 49 | 0.110 |
Why?
|
| Sulfides | 1 | 2013 | 58 | 0.110 |
Why?
|
| Species Specificity | 2 | 2019 | 233 | 0.110 |
Why?
|
| Manganese | 1 | 2013 | 59 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2014 | 79 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 555 | 0.110 |
Why?
|
| Zinc Fingers | 1 | 2012 | 25 | 0.110 |
Why?
|
| Digestion | 2 | 2022 | 13 | 0.110 |
Why?
|
| Anaerobiosis | 2 | 2022 | 13 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 231 | 0.110 |
Why?
|
| HIV Infections | 3 | 2015 | 2207 | 0.110 |
Why?
|
| Phosphorylation | 1 | 2015 | 878 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2012 | 100 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 200 | 0.100 |
Why?
|
| Myocardial Reperfusion | 1 | 2011 | 10 | 0.100 |
Why?
|
| Odds Ratio | 3 | 2020 | 517 | 0.100 |
Why?
|
| Lipids | 2 | 2022 | 222 | 0.100 |
Why?
|
| Infectious Anemia Virus, Equine | 1 | 2010 | 2 | 0.100 |
Why?
|
| Area Under Curve | 2 | 2020 | 91 | 0.090 |
Why?
|
| Guinea Pigs | 2 | 2010 | 141 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 2010 | 154 | 0.090 |
Why?
|
| Immunoglobulin G | 2 | 2014 | 232 | 0.090 |
Why?
|
| Sonication | 1 | 2009 | 15 | 0.090 |
Why?
|
| Absorbable Implants | 1 | 2009 | 3 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 968 | 0.090 |
Why?
|
| Amino Acid Sequence | 3 | 2019 | 1124 | 0.090 |
Why?
|
| Peptides | 1 | 2012 | 308 | 0.090 |
Why?
|
| Polyesters | 1 | 2009 | 21 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2022 | 57 | 0.090 |
Why?
|
| T-Lymphocytes | 2 | 2009 | 341 | 0.090 |
Why?
|
| Polyethylene Glycols | 1 | 2009 | 80 | 0.090 |
Why?
|
| Polymers | 1 | 2009 | 117 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 249 | 0.080 |
Why?
|
| Eutrophication | 1 | 2007 | 4 | 0.080 |
Why?
|
| Color | 1 | 2007 | 19 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2023 | 1353 | 0.080 |
Why?
|
| Nanostructures | 1 | 2009 | 133 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 182 | 0.080 |
Why?
|
| Glycosylation | 2 | 2022 | 92 | 0.080 |
Why?
|
| Blood Donors | 1 | 2006 | 17 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2018 | 1422 | 0.070 |
Why?
|
| Environmental Monitoring | 1 | 2007 | 188 | 0.070 |
Why?
|
| Neutralization Tests | 1 | 2006 | 53 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 4 | 2010 | 649 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 1490 | 0.070 |
Why?
|
| Immunization | 1 | 2006 | 90 | 0.070 |
Why?
|
| HIV Core Protein p24 | 1 | 2005 | 10 | 0.070 |
Why?
|
| Pichia | 1 | 2005 | 10 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 2 | 2022 | 282 | 0.070 |
Why?
|
| Fusion Proteins, gag-pol | 1 | 2004 | 3 | 0.060 |
Why?
|
| Gene Products, env | 1 | 2004 | 23 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2004 | 59 | 0.060 |
Why?
|
| Alleles | 2 | 2016 | 284 | 0.060 |
Why?
|
| Pyrazines | 1 | 2024 | 23 | 0.060 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2023 | 17 | 0.060 |
Why?
|
| Esculin | 1 | 2023 | 1 | 0.060 |
Why?
|
| Uridine Diphosphate | 1 | 2023 | 2 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2006 | 328 | 0.060 |
Why?
|
| Scopoletin | 1 | 2023 | 4 | 0.060 |
Why?
|
| Furans | 1 | 2024 | 34 | 0.060 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2024 | 52 | 0.060 |
Why?
|
| Terpenes | 1 | 2023 | 28 | 0.060 |
Why?
|
| Indicator Dilution Techniques | 1 | 2023 | 1 | 0.060 |
Why?
|
| Glucosides | 1 | 2023 | 15 | 0.060 |
Why?
|
| Fluorescence | 1 | 2023 | 117 | 0.060 |
Why?
|
| Protein Kinase C-epsilon | 2 | 2014 | 14 | 0.060 |
Why?
|
| Polyethylene | 1 | 2022 | 3 | 0.060 |
Why?
|
| Polyvinyl Chloride | 1 | 2022 | 4 | 0.060 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2023 | 75 | 0.060 |
Why?
|
| Plastics | 1 | 2022 | 9 | 0.060 |
Why?
|
| Adipocytes, Brown | 1 | 2022 | 8 | 0.060 |
Why?
|
| Gene Flow | 1 | 2022 | 10 | 0.060 |
Why?
|
| Hydroxylation | 1 | 2022 | 14 | 0.060 |
Why?
|
| Drug Resistance, Microbial | 1 | 2022 | 26 | 0.060 |
Why?
|
| Melanoma | 1 | 2024 | 91 | 0.060 |
Why?
|
| Glycosides | 1 | 2022 | 19 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 64 | 0.050 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 39 | 0.050 |
Why?
|
| Adipocytes | 1 | 2022 | 54 | 0.050 |
Why?
|
| Thymus Gland | 1 | 2022 | 77 | 0.050 |
Why?
|
| Flavonoids | 1 | 2022 | 78 | 0.050 |
Why?
|
| Alveolar Process | 1 | 2021 | 3 | 0.050 |
Why?
|
| Bromates | 1 | 2021 | 2 | 0.050 |
Why?
|
| RNA | 1 | 2024 | 234 | 0.050 |
Why?
|
| Porphyromonas gingivalis | 1 | 2021 | 23 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2024 | 181 | 0.050 |
Why?
|
| Caprylates | 1 | 2021 | 6 | 0.050 |
Why?
|
| Glucose | 1 | 2023 | 217 | 0.050 |
Why?
|
| Methane | 1 | 2021 | 7 | 0.050 |
Why?
|
| Bioreactors | 1 | 2021 | 21 | 0.050 |
Why?
|
| Fluorocarbons | 1 | 2021 | 19 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 176 | 0.050 |
Why?
|
| Lysosomes | 1 | 2021 | 80 | 0.050 |
Why?
|
| Base Sequence | 2 | 2015 | 932 | 0.050 |
Why?
|
| Leukoplakia | 1 | 2020 | 2 | 0.050 |
Why?
|
| Testosterone | 1 | 2021 | 181 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2021 | 146 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 292 | 0.050 |
Why?
|
| Hela Cells | 1 | 2021 | 344 | 0.050 |
Why?
|
| Patient Admission | 1 | 2020 | 40 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 200 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2023 | 250 | 0.050 |
Why?
|
| Mouth | 1 | 2020 | 44 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 2128 | 0.050 |
Why?
|
| Thermogravimetry | 1 | 2019 | 4 | 0.050 |
Why?
|
| Binding Sites | 2 | 2013 | 597 | 0.050 |
Why?
|
| Viscosity | 1 | 2019 | 37 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2020 | 116 | 0.050 |
Why?
|
| Anesthetics, Local | 2 | 2009 | 21 | 0.040 |
Why?
|
| Crystallization | 1 | 2019 | 82 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 147 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2019 | 257 | 0.040 |
Why?
|
| Myocardial Infarction | 2 | 2012 | 221 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2022 | 366 | 0.040 |
Why?
|
| Disease Progression | 1 | 2021 | 580 | 0.040 |
Why?
|
| DNA, Plant | 1 | 2019 | 13 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 164 | 0.040 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2019 | 9 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 424 | 0.040 |
Why?
|
| Epitope Mapping | 2 | 2010 | 31 | 0.040 |
Why?
|
| Protein Binding | 2 | 2014 | 913 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2019 | 120 | 0.040 |
Why?
|
| Research Design | 1 | 2020 | 292 | 0.040 |
Why?
|
| Prevalence | 1 | 2023 | 1425 | 0.040 |
Why?
|
| Vaccines, Synthetic | 2 | 2009 | 72 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 255 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2018 | 85 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2018 | 106 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 1530 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2018 | 197 | 0.040 |
Why?
|
| Acetylcholinesterase | 1 | 2017 | 53 | 0.040 |
Why?
|
| Algorithms | 1 | 2020 | 435 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 145 | 0.040 |
Why?
|
| DNA, Archaeal | 1 | 2016 | 5 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2016 | 35 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2017 | 269 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 104 | 0.040 |
Why?
|
| Cell Survival | 2 | 2011 | 818 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2010 | 751 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 1300 | 0.040 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2016 | 20 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 255 | 0.040 |
Why?
|
| Publication Bias | 1 | 2016 | 2 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2016 | 188 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2018 | 306 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 577 | 0.030 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2015 | 55 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2015 | 122 | 0.030 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2014 | 8 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 1442 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2014 | 5 | 0.030 |
Why?
|
| Actinin | 1 | 2014 | 7 | 0.030 |
Why?
|
| Prazosin | 1 | 2014 | 11 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 984 | 0.030 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2014 | 15 | 0.030 |
Why?
|
| Doxycycline | 1 | 2014 | 30 | 0.030 |
Why?
|
| Protein Stability | 1 | 2014 | 40 | 0.030 |
Why?
|
| Cognition | 1 | 2017 | 373 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2014 | 54 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2013 | 26 | 0.030 |
Why?
|
| Quantum Dots | 1 | 2013 | 26 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 181 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 1681 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2014 | 392 | 0.030 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2012 | 7 | 0.030 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2012 | 10 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2012 | 14 | 0.030 |
Why?
|
| Environment | 1 | 2013 | 130 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 338 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2012 | 71 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 2013 | 81 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2014 | 287 | 0.030 |
Why?
|
| Air Pressure | 1 | 2011 | 1 | 0.030 |
Why?
|
| Forecasting | 1 | 2012 | 124 | 0.030 |
Why?
|
| KATP Channels | 1 | 2011 | 11 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2011 | 19 | 0.030 |
Why?
|
| Cattle | 1 | 2013 | 472 | 0.030 |
Why?
|
| Cystine | 1 | 2011 | 12 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2012 | 104 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2011 | 59 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 180 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 131 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2011 | 89 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2012 | 160 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 122 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 423 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 18 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 407 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 168 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2009 | 25 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 859 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2009 | 38 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 5035 | 0.020 |
Why?
|
| Phase Transition | 1 | 2009 | 9 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 964 | 0.020 |
Why?
|
| Drug Compounding | 1 | 2009 | 70 | 0.020 |
Why?
|
| Porosity | 1 | 2009 | 32 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2010 | 235 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 249 | 0.020 |
Why?
|
| Rheology | 1 | 2009 | 24 | 0.020 |
Why?
|
| Micelles | 1 | 2009 | 31 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 237 | 0.020 |
Why?
|
| Materials Testing | 1 | 2009 | 71 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 161 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2009 | 87 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2009 | 75 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 383 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2009 | 161 | 0.020 |
Why?
|
| Temperature | 1 | 2009 | 275 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2007 | 36 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 490 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 347 | 0.020 |
Why?
|
| Thiazoles | 1 | 2007 | 71 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2007 | 162 | 0.020 |
Why?
|
| Vaccinia virus | 1 | 2007 | 10 | 0.020 |
Why?
|
| Codon | 1 | 2007 | 38 | 0.020 |
Why?
|
| Vaccines, Subunit | 1 | 2007 | 30 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 376 | 0.020 |
Why?
|
| Fermentation | 1 | 2005 | 25 | 0.020 |
Why?
|
| Hepatitis C | 1 | 2006 | 120 | 0.020 |
Why?
|
| Smoking | 1 | 2012 | 903 | 0.020 |
Why?
|
| Mutation | 1 | 2009 | 1023 | 0.020 |
Why?
|
| Vaccination | 1 | 2007 | 259 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 195 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2004 | 90 | 0.020 |
Why?
|
| Transfection | 1 | 2004 | 496 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 834 | 0.010 |
Why?
|